2014 Susan G Komen Race for the Cure of breast cancer is Saturday, September 13 in downtown Cleveland, African-American women are more likely to die of breast cancer than any other race of women, data show
CLEVELAND, Ohio- The annual northeast Ohio Susan G. Komen Race for the Cure [for breast cancer] will begin and end in downtown Cleveland, on Saturday, September 13, 2014 at the corner of East Ninth Street and Lakeside Avenue at Malls B and C. A survivor ceremony will be held at 8:00 am, followed by a five mile walk at 9:15 am, a one mile walk at 9:30 am, and a kids dash at 10:30 am.
Not counting some forms of skin cancer, breast cancer is the most common cancer among women across racial lines, and the second leading cause of death in women, second only to lung cancer, data show.
Overall, African-American women are more likely to die of breast cancer than any other race of women, statistics show.
Documented History
About Susan G. Komen®
Susan G. Komen fought breast cancer with her heart, body and soul. Throughout her diagnosis, treatments, and endless days in the hospital, she spent her time thinking of ways to make life better for other women battling breast cancer instead of worrying about her own situation. Moved by Susan’s compassion for others and commitment to making a difference, Nancy G. Brinker promised her sister that she would do everything in her power to end breast cancer.
Though Komen lost her battle with the disease, her legacy lives on through the work of Susan G. Komen, the organization Nancy started in her honor. Since its founding in 1982, Komen has funded more than $800 million in research and provided more that $1.7 billion in funding to screening, education, treatment and psycho-social support programs
serving millions of people in more than 30 countries worldwide. (www.clevelandurbannews.com) / (www.kathywraycolemanonlinenewsblog.com)
Though Komen lost her battle with the disease, her legacy lives on through the work of Susan G. Komen, the organization Nancy started in her honor. Since its founding in 1982, Komen has funded more than $800 million in research and provided more that $1.7 billion in funding to screening, education, treatment and psycho-social support programs
serving millions of people in more than 30 countries worldwide. (www.clevelandurbannews.com) / (www.kathywraycolemanonlinenewsblog.com)
Comments